ツムラの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/09/19 | 3,950 | 3,975 | 3,941 | 3,950 | +54 | +1.4% | 142,600 |
2024/09/18 | 3,861 | 3,900 | 3,859 | 3,896 | +30 | +0.8% | 196,800 |
2024/09/17 | 3,889 | 3,910 | 3,820 | 3,866 | +6 | +0.2% | 251,700 |
2024/09/13 | 3,844 | 3,875 | 3,840 | 3,860 | -2 | -0.1% | 182,600 |
2024/09/12 | 3,859 | 3,923 | 3,822 | 3,862 | +59 | +1.6% | 191,700 |
2024/09/11 | 3,941 | 3,941 | 3,777 | 3,803 | -138 | -3.5% | 176,200 |
2024/09/10 | 3,959 | 3,984 | 3,934 | 3,941 | +1 | ±0% | 234,400 |
2024/09/09 | 3,863 | 3,952 | 3,820 | 3,940 | +7 | +0.2% | 274,400 |
2024/09/06 | 3,882 | 3,954 | 3,882 | 3,933 | +37 | +0.9% | 292,100 |
2024/09/05 | 3,866 | 3,941 | 3,858 | 3,896 | +47 | +1.2% | 213,800 |
2024/09/04 | 3,915 | 3,947 | 3,838 | 3,849 | -136 | -3.4% | 239,100 |
2024/09/03 | 3,943 | 3,987 | 3,940 | 3,985 | +42 | +1.1% | 116,900 |
2024/09/02 | 4,007 | 4,007 | 3,915 | 3,943 | -84 | -2.1% | 237,700 |
2024/08/30 | 3,989 | 4,029 | 3,956 | 4,027 | +8 | +0.2% | 353,500 |
2024/08/29 | 4,043 | 4,063 | 3,994 | 4,019 | -30 | -0.7% | 192,000 |
2024/08/28 | 4,020 | 4,049 | 4,014 | 4,049 | +46 | +1.1% | 144,000 |
2024/08/27 | 4,014 | 4,015 | 3,982 | 4,003 | +22 | +0.6% | 97,300 |
2024/08/26 | 3,988 | 3,997 | 3,934 | 3,981 | -16 | -0.4% | 153,500 |
2024/08/23 | 4,000 | 4,009 | 3,976 | 3,997 | -5 | -0.1% | 209,000 |
2024/08/22 | 3,967 | 4,049 | 3,951 | 4,002 | +89 | +2.3% | 327,900 |
2024/08/21 | 3,924 | 3,947 | 3,892 | 3,913 | -35 | -0.9% | 115,400 |
2024/08/20 | 3,957 | 3,970 | 3,910 | 3,948 | +41 | +1% | 160,800 |
2024/08/19 | 3,937 | 3,967 | 3,889 | 3,907 | -19 | -0.5% | 256,900 |
2024/08/16 | 3,870 | 3,926 | 3,850 | 3,926 | +113 | +3% | 264,000 |
2024/08/15 | 3,824 | 3,860 | 3,788 | 3,813 | -11 | -0.3% | 181,000 |
2024/08/14 | 3,880 | 3,915 | 3,798 | 3,824 | -3 | -0.1% | 231,900 |
2024/08/13 | 3,742 | 3,829 | 3,742 | 3,827 | +125 | +3.4% | 275,500 |
2024/08/09 | 3,793 | 3,820 | 3,669 | 3,702 | -21 | -0.6% | 305,300 |
2024/08/08 | 3,710 | 3,834 | 3,706 | 3,723 | -57 | -1.5% | 304,400 |
2024/08/07 | 3,724 | 3,939 | 3,641 | 3,780 | +165 | +4.6% | 637,200 |
2024/08/06 | 3,773 | 3,773 | 3,584 | 3,615 | +262 | +7.8% | 859,500 |
2024/08/05 | 3,517 | 3,650 | 3,316 | 3,353 | -304 | -8.3% | 683,100 |
2024/08/02 | 3,706 | 3,783 | 3,656 | 3,657 | -170 | -4.4% | 552,700 |
2024/08/01 | 3,937 | 3,937 | 3,806 | 3,827 | -178 | -4.4% | 382,400 |
2024/07/31 | 3,940 | 4,005 | 3,932 | 4,005 | +31 | +0.8% | 211,000 |
2024/07/30 | 3,948 | 3,983 | 3,921 | 3,974 | +26 | +0.7% | 229,700 |
2024/07/29 | 3,934 | 3,978 | 3,923 | 3,948 | +68 | +1.8% | 198,500 |
2024/07/26 | 3,925 | 3,945 | 3,868 | 3,880 | -34 | -0.9% | 305,600 |
2024/07/25 | 3,950 | 3,955 | 3,891 | 3,914 | -81 | -2% | 278,400 |
2024/07/24 | 3,995 | 4,055 | 3,972 | 3,995 | -48 | -1.2% | 282,200 |
2024/07/23 | 3,990 | 4,056 | 3,983 | 4,043 | +72 | +1.8% | 245,700 |
2024/07/22 | 3,990 | 4,013 | 3,962 | 3,971 | -9 | -0.2% | 260,800 |
2024/07/19 | 3,950 | 4,005 | 3,934 | 3,980 | +24 | +0.6% | 267,300 |
2024/07/18 | 3,977 | 3,996 | 3,946 | 3,956 | -53 | -1.3% | 398,700 |
2024/07/17 | 4,105 | 4,114 | 4,001 | 4,009 | -70 | -1.7% | 575,700 |
2024/07/16 | 4,158 | 4,158 | 4,074 | 4,079 | -121 | -2.9% | 404,400 |
2024/07/12 | 4,133 | 4,229 | 4,130 | 4,200 | +8 | +0.2% | 301,300 |
2024/07/11 | 4,220 | 4,227 | 4,179 | 4,192 | -16 | -0.4% | 357,100 |
2024/07/10 | 4,218 | 4,223 | 4,153 | 4,208 | +32 | +0.8% | 304,500 |
2024/07/09 | 4,173 | 4,201 | 4,149 | 4,176 | +22 | +0.5% | 264,700 |
151~
200
件表示中 / 3693件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ツムラ | 432,700円 | +20.9% | +87.3% | 3.14% | 9.67倍 | 1.12倍 |
|
医療用漢方薬で国内シェア8割超。高齢者、がん支持療法、女性関連の3領域を重点に市場深耕 |
久光薬 | 437,300円 | +5.8% | +1.2% | 2.74% | 14.51倍 | 1.15倍 |
|
貼る鎮痛消炎剤首位。医療用シェア5割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
住友ファーマ | 89,900円 | +26.8% | - | 0.00% | 15.13倍 | 3.12倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
ペプチド | 190,600円 | +5.0% | +1.5% | 0.00% | 16.36倍 | 4.35倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
日本新薬 | 348,400円 | +7.9% | +8.9% | 3.56% | 7.45倍 | 1.00倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
市場注目の銘柄
チャート関連のコラム